Saturday, June 07, 2025 | 09:02 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Top headlines: India's first nasal vaccine for Covid-19; new seat belt rule

Business Standard brings you the top headlines at this hour

Nasal spray market heats up as Covid-19 curbs ease, people return to work
premium

iNCOVACC is a chimpanzee adenovirus vectored recombinant nasal vaccine that has been specifically formulated to allow intra-nasal delivery through nasal drops.

BS Web Team New Delhi
The Drugs Controller General of India (DCGI) on Tuesday approved the country’s first intra-nasal Covid-19 vaccine — Bharat Biotech’s iNCOVACC — for restricted emergency use in those aged above 18 years. Days after a car accident killed former Tata group chairman Cyrus Mistry, Union Minister for Road Transport & Highways Nitin Gadkari on Tuesday announced the central government would now make it mandatory for all travellers in a car to wear a seat belt. Read more on these in our top headlines.

India's first nasal vaccine for Covid-19 gets DCGI nod for emergency use

The Drugs Controller General of India